{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T16:53:38Z","timestamp":1779296018661,"version":"3.51.4"},"reference-count":36,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Immunology"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.humimm.2019.07.283","type":"journal-article","created":{"date-parts":[[2019,7,18]],"date-time":"2019-07-18T01:14:34Z","timestamp":1563412474000},"page":"871-877","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["CD56brightCD16\u2212 natural killer cells are shifted toward an IFN-\u03b3-promoting phenotype with reduced regulatory capacity in osteoarthritis"],"prefix":"10.1016","volume":"80","author":[{"given":"Huaqing","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minghui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongbing","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bing","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hua","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junru","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.humimm.2019.07.283_b0005","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.jaut.2009.09.008","article-title":"Recent insights in the epidemiology of autoimmune diseases: improved prevalence estimates and understanding of clustering of diseases","volume":"33","author":"Cooper","year":"2009","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.humimm.2019.07.283_b0010","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1056\/NEJMra043430","article-title":"Inflammation, atherosclerosis, and coronary artery disease","volume":"352","author":"Hansson","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.humimm.2019.07.283_b0015","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.biopha.2016.01.036","article-title":"Downregulation of IL-10 secretion by Treg cells in osteoarthritis is associated with a reduction in Tim-3 expression","volume":"79","author":"Li","year":"2016","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.humimm.2019.07.283_b0020","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.smim.2012.12.001","article-title":"The immune system\u2019s involvement in obesity-driven type 2 diabetes","volume":"24","author":"Shu","year":"2012","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.humimm.2019.07.283_b0025","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1016\/j.joca.2012.08.027","article-title":"Synovial inflammation, immune cells and their cytokines in osteoarthritis: a review","volume":"20","author":"de Lange-Brokaar","year":"2012","journal-title":"Osteoarthr. Cartil."},{"key":"10.1016\/j.humimm.2019.07.283_b0030","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2016.00606","article-title":"Regulatory functions of natural killer cells in multiple sclerosis","author":"Gross","year":"2016","journal-title":"Front. Immunol."},{"key":"10.1016\/j.humimm.2019.07.283_b0035","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.jaut.2012.05.006","article-title":"Regulatory NK cells in autoimmune disease","author":"Tian","year":"2012","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.humimm.2019.07.283_b0040","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2014.00159","article-title":"Cross-talks between natural killer cells and distinct subsets of dendritic cells","author":"Ferlazzo","year":"2014","journal-title":"Front. Immunol."},{"key":"10.1016\/j.humimm.2019.07.283_b0045","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1002\/art.10410","article-title":"A subset of natural killer cells is greatly expanded within inflamed joints","volume":"46","author":"Dalbeth","year":"2002","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.humimm.2019.07.283_b0050","doi-asserted-by":"crossref","first-page":"13835","DOI":"10.18632\/oncotarget.3453","article-title":"Characterization of tumor infiltrating natural killer cell subset","volume":"6","author":"Levi","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.humimm.2019.07.283_b0055","doi-asserted-by":"crossref","first-page":"3052","DOI":"10.1182\/blood-2002-09-2876","article-title":"CD56bright natural killer cells are present in human lymph nodes and are activated by T cell-derived IL-2: a potential new link between adaptive and innate immunity","volume":"101","author":"Fehniger","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.humimm.2019.07.283_b0060","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1111\/j.1365-2567.2008.03027.x","article-title":"CD56bright natural killer (NK) cells: an important NK cell subset","author":"Poli","year":"2009","journal-title":"Immunology"},{"key":"10.1016\/j.humimm.2019.07.283_b0065","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/imm.12224","article-title":"Subsets of human natural killer cells and their regulatory effects","author":"Fu","year":"2014","journal-title":"Immunology"},{"key":"10.1016\/j.humimm.2019.07.283_b0070","doi-asserted-by":"crossref","first-page":"3146","DOI":"10.1182\/blood.V97.10.3146","article-title":"Human natural killer cells: a unique innate immunoregulatory role for the CD56 bright subset","volume":"97","author":"Cooper","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.humimm.2019.07.283_b0075","doi-asserted-by":"crossref","first-page":"16606","DOI":"10.1073\/pnas.0407522101","article-title":"Distinct roles of IL-12 and IL-15 in human natural killer cell activation by dendritic cells from secondary lymphoid organs","volume":"101","author":"Ferlazzo","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.humimm.2019.07.283_b0080","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1084\/jem.20050128","article-title":"IL-18-induced CD83+CCR7+ NK helper cells","volume":"202","author":"Mailliard","year":"2005","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.humimm.2019.07.283_b0085","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1002\/eji.200323986","article-title":"The natural killer cell-mediated killing of autologous dendritic cells is confined to a cell subset expressing CD94\/NKG2A, but lacking inhibitory killer Ig-like receptors","volume":"33","author":"Della","year":"2003","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.humimm.2019.07.283_b0090","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0039170","article-title":"Dendritic cell editing by activated natural killer cells results in a more protective cancer-specific immune response","volume":"7","author":"Morandi","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.humimm.2019.07.283_b0095","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1084\/jem.171.5.1509","article-title":"Functional consequences of interleukin 2 receptor expression on resting human lymphocytes. Identification of a novel natural killer cell subset with high affinity receptors","volume":"171","author":"Caligiuri","year":"1990","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.humimm.2019.07.283_b0100","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.4049\/jimmunol.0902238","article-title":"An IL-2 paradox: blocking CD25 on T cells induces IL-2-driven activation of CD56bright NK cells","volume":"185","author":"Martin","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.humimm.2019.07.283_b0105","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jaut.2016.04.003","article-title":"Dysregulation of regulatory CD56bright NK cells\/T cells interactions in multiple sclerosis","volume":"72","author":"Laroni","year":"2016","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.humimm.2019.07.283_b0110","doi-asserted-by":"crossref","first-page":"781","DOI":"10.4049\/jimmunol.1100789","article-title":"Unexpected role for granzyme K in CD56bright NK cell-mediated immunoregulation of multiple sclerosis","volume":"187","author":"Jiang","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.humimm.2019.07.283_b0115","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0026173","article-title":"IL-27 imparts immunoregulatory function to human NK cell subsets","volume":"6","author":"Laroni","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.humimm.2019.07.283_b0120","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0031959","article-title":"Cytotoxicity of CD56 bright NK cells towards autologous activated CD4 + T cells is mediated through NKG2D, LFA-1 and TRAIL and dampened via CD94\/NKG2A","volume":"7","author":"Nielsen","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.humimm.2019.07.283_b0125","doi-asserted-by":"crossref","first-page":"E2973","DOI":"10.1073\/pnas.1524924113","article-title":"Impaired NK-mediated regulation of T-cell activity in multiple sclerosis is reconstituted by IL-2 receptor modulation","volume":"113","author":"Gross","year":"2016","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.humimm.2019.07.283_b0130","first-page":"356","article-title":"T cells in osteoarthritis: alterations and beyond","volume":"8","author":"Li","year":"2017","journal-title":"Front Immunol. Front. Media SA"},{"key":"10.1016\/j.humimm.2019.07.283_b0135","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1016\/j.joca.2017.06.007","article-title":"CD56(+)\/CD16(-) Natural Killer cells expressing the inflammatory protease granzyme A are enriched in synovial fluid from patients with osteoarthritis","volume":"25","author":"Jaime","year":"2017","journal-title":"Osteoarthr. Cartil."},{"key":"10.1016\/j.humimm.2019.07.283_b0140","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1006\/clin.1994.1173","article-title":"Expression of granzymes A and B in synovial tissue from patients with rheumatoid arthritis and osteoarthritis","volume":"73","author":"Kummer","year":"1994","journal-title":"Clin. Immunol. Immunopathol."},{"key":"10.1016\/j.humimm.2019.07.283_b0145","doi-asserted-by":"crossref","first-page":"3799","DOI":"10.1002\/art.27751","article-title":"Synovial tissue-infiltrating natural killer cells in osteoarthritis and periprosthetic inflammation","volume":"62","author":"Huss","year":"2010","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.humimm.2019.07.283_b0150","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1136\/ard.16.4.494","article-title":"Radiological assessment of osteoarthritis","volume":"16","author":"Kellgren","year":"1957","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.humimm.2019.07.283_b0155","doi-asserted-by":"crossref","DOI":"10.1615\/CritRevImmunol.2016017387","article-title":"Metabolic regulation of natural killer cell IFN-\u03b3 production","author":"Mah","year":"2016","journal-title":"Crit. Rev. Immunol."},{"key":"10.1016\/j.humimm.2019.07.283_b0160","doi-asserted-by":"crossref","DOI":"10.1002\/eji.201344072","article-title":"NK cells gain higher IFN-\u03b3 competence during terminal differentiation","author":"Luetke-Eversloh","year":"2014","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.humimm.2019.07.283_b0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.immuni.2007.04.010","article-title":"Acquisition of murine NK cell cytotoxicity requires the translation of a pre-existing pool of granzyme B and perforin mRNAs","author":"Fehniger","year":"2007","journal-title":"Immunity"},{"key":"10.1016\/j.humimm.2019.07.283_b0170","doi-asserted-by":"crossref","DOI":"10.1002\/jlb.58.2.225","article-title":"Cellular and molecular mechanisms of IFN-\u03b3 production induced by IL-2 and IL-12 in a human NK cell line","author":"Ye","year":"1995","journal-title":"J. Leukoc Biol."},{"key":"10.1016\/j.humimm.2019.07.283_b0175","doi-asserted-by":"crossref","DOI":"10.1038\/icb.2010.78","article-title":"Activating and inhibitory receptors of natural killer cells","author":"Pegram","year":"2011","journal-title":"Immunol. Cell Biol."},{"key":"10.1016\/j.humimm.2019.07.283_b0180","doi-asserted-by":"crossref","DOI":"10.1006\/cimm.1998.1363","article-title":"Interleukin-12 is expressed by infiltrating macrophages and synovial lining cells in rheumatoid arthritis and osteoarthritis","author":"Sakkas","year":"1998","journal-title":"Cell Immunol."}],"container-title":["Human Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885919303143?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885919303143?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T11:51:51Z","timestamp":1759319511000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0198885919303143"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":36,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["S0198885919303143"],"URL":"https:\/\/doi.org\/10.1016\/j.humimm.2019.07.283","relation":{},"ISSN":["0198-8859"],"issn-type":[{"value":"0198-8859","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CD56brightCD16\u2212 natural killer cells are shifted toward an IFN-\u03b3-promoting phenotype with reduced regulatory capacity in osteoarthritis","name":"articletitle","label":"Article Title"},{"value":"Human Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humimm.2019.07.283","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}